Proteometabolic analysis in urology


Cite item

Full Text

Abstract

References

  1. Льюин Б. Гены. М.: Мир; 1987.
  2. Greene R. A., Jenkins T. M., Wapner R. J. The new genetic era in reproductive medicine: possibilities, probabilities and problems. Int. J. Fertil. Womens Med. 2001; 46 (3): 169-183.
  3. Huson D. H., Reinert K., Kravitz S. A. et al. Design of a compartmentalized shotgun assembler for the human genome. Bioinformatics 2001; 17 (1): 132-139.
  4. Semsarian C., Seidman C. E. Molecular medicine in the 21st century. Intern. Med. J. 2001; 31 (1): 53-59.
  5. Werner Th. Identification and functional modeling of DNA sequence elements of transcription. Briefings in Bioinformat. 2000; 1 (4): 372-380.
  6. Bertram H. C., Eggers N., Eller N. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Analyt. Chem. 2009; 81 (21): 9188-9193.
  7. Crews B., Wikoff W. R., Patti G. J. et al. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomic data. Analyt. Chem. 2009; 81 (20): 8538-8544.
  8. Mello B. P., Abrantes E. F., Torres C. H. et al. No-match ORESTES explored as tumor markers. Nucleic Acids Res. 2009; 37 (8): 2607-2617.
  9. Hortin G. L., Jortani S. A., Ritchie J. C. Jr. et al. Proteomics: a new diagnostic frontier! Clin. Chem. 2006; 52 (7): 1218-1222.
  10. Khan A., Packer N. H. Simple urinary sample preparation for proteomic analysis. J. Proteome Res. 2006; 5 (10: 2824-2838.
  11. Lee S. W., Lee K. I., Kim J. Y. Revealing urologic diseases by proteomic techniques. J. Chromatogr. Analyt. Technol. Biomed. Life Sci. 2005; 5; 203-213.
  12. Nelson P. S., Clegg N., Eroglu B., Hawkins V. The prostate expression database (PEDB): status and enhancements in 2000. Nucleic Acids Res. 2000; 28 (1): 212-213.
  13. Cazares L. H., Adam B. L., Ward M. D. , Nasim S. Normal, benign, preneoplastic and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorptiob/ionization mass spectrometry. Clin. Cancer Res. 2002; 8: 2541-2552.
  14. Чугунов А. Полет бабочки, или немного о пользе структурной геномики. Наука и жизнь 2010; 1: 22-29.
  15. M'Koma A. E., Blum D. L., Norris J. L. et al. Detection of preneoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem. Biophys. Res. Commun. 2007; 353 (3): 829-834.
  16. Park Y., Downing S. R., Kim D. et al. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data. Bioinformatics. 2007; 23 (12): 1451-1458.
  17. Rehman I., Azzouzi A. R., Catto J. W. et al. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology 2004; 64 (6): 1238-1243.
  18. Wu D. L., Zhang W. H., Wang W. J. et al. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern. Technol. Cancer Res. Treat. 2008; 7 (3): 155-160.
  19. Cayatte C., Pons Q., Guigoins J. M. et al. Protein profiling of rat ventral prostate following chronic finasteride administration: identification and localization of a novel putative androgen-regulated protein. Mol. Cell. Proteomics. 2006; 5 (11): 2031-2043.
  20. Desireddi N. V., Campbell P. L., Stern J. A., Sobkoviak R. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha as possible biomarkers for the chronic pelvic pain syndrome. J. Urol. (Baltimore) 2008; 179 (5): 1857- 1861.
  21. Dutcowski J., Gambin A. On consensus biomarker selection. BMC. Bioinformat. 2007; 8 (5): 5.
  22. Oehr P. Proteomics as a tool for detection of nuclear matrix proteins and new biomarkers for screening of early tumors stage. Anticancer Res. 2003; 23 (2A): 805-812.
  23. Castelli T., Cimino S., Magno C., Morgia G. Molecular markers for prostatic cancer. Front. Biosci. (Elite Ed.) 2010; 1-2: 641- 656.
  24. Chuan Y., Pang S. T., Bergh A., Norstedt G. Androgens induce CD-9 in human prostate tissue. Int. J. Androl 2005; 28 (5): 291-296.
  25. Feldman A. S., Banyard J., Wu C. L. et al. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin. Cancer Res. 2009; 15 (3): 1024-1031.
  26. Kehinde E. O., Maghrebi M. A., Anim J. T. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers. Can. J. Urol. 2008; 15 (2): 3967- 3974.
  27. Pang J., Liu W. P., Liu X. P. et al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. Proteome Res. 2010; 9 (1): 216-226.
  28. Parekh D. J., Ankerst D. P., Troyer D. et al. Biomarkers for Tostate cancer detection. J. Urol. (Baltimore) 2007; 178 (6): 2252-2259.
  29. Ploussard G., de la Taille A. Urine biomarkers in prostate cancer. Nat. Rev. Urol. 2010; 7 (2): 101-109.
  30. Tan L. B., Chen K. T., Yuan Y. C. et al. Identification of urine PLK2 (as a marker of bladder tumors by proteomic analysis. Wld J. Urol. 2010; 28 (1): 117-122.
  31. Максимов В. А. Оптимизация ранней диагностики заболеваний предстательной железы: Автореф. дис. ... д-ра мед. наук. М.; 2009.
  32. Unwin R. D., Knowles N. A., Selby P. J., Banks R. E. Urological malignancies and the proteomic-genomic interface. Electrophoresis 1999; 20 (18): 3629-3637.
  33. Meehan K. L., Holland J., Dawkins H. J. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate 2002; 50 (1): 54-63.
  34. Leiblich A., Cross S. S., Catto J. W. et al. Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A. Prostate 2007; 67 (16): 1761-1769.
  35. Xu G., Xiang C. Q., Lu X. et al. Proteomic analysis, in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses. Zhonghua Yi Xue Za Zhi. 2008; 88 (12): 858-860.
  36. Xu G., Xiang C. Q., Lu Y. et al. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett. 2009; 282 (2): 205-213.
  37. Utleg A. G., Yi E. C., Xie T. et al. Proteomic analysis of human prostasomes. Prostate 2003; 56 (2): 150-160.
  38. Poliakov A., Spilman M., Dokland T. et al. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 2009; 69 (2): 159-167.
  39. Lexander H., Franzen B., Hirschberg D. et al. Differential protein expression in anatomical zones of the prostate. Proteomics 2005; 5 (10): 2570-2576.
  40. Canales B. K., Anderson L., Higgins L. et al. Proteomic analysis of a matrix stone: a case report. Urol. Res. 2009; 37 (6): 323- 329.
  41. Chen W. C., Lai C. C., Tsai Y. et al. Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study. J. Clin. Lab. Anal. 2008; 22 (1): 77-85.
  42. Kistler A. D., Mischak H., Poster D. et al. Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009; 76 (1): 89-96.
  43. Пушкарь Д. Ю., Сегал А. С. Хронический простатит: что нас тревожит? Андрол. и генит. хир. 2008; 1: 43-46.
  44. Сагалов А. В. Амбулаторно-поликлиническая андрология: Руководство для врачей. М.: Мед. книга; Н. Новгород: Изд. НГМА; 2006.
  45. Meares Jr. E. M. M. D. Prostatitis and related disorders. In: Walsh: Campbell's urology. 7-th; 1998; vol. 1: 458-486.
  46. Partin A. W., Coffey D. S. The molecular biology, endocrinology and physiology of the prostate and seminal vesicles. In: Walsh: Campbell's urology. 7-th ed., 1998; vol. 2: 1-54.
  47. Kirby R. S., Lowe D., Bultitude M. I., Shuttleworth K. E. D. Intra-prostatic urinary reflux: An aetiological factor in abacterial prostatitis. Br. J. Urol. 1982; 54: 729.
  48. Пятакова Е. И., Каманцева С. М., Беляков Н. Ф. Хронический простатит - болезнь или симптом? В кн.: Материалы конференции "Мужское здоровье" 19-21 нояб. 2003, Москва. М.; 2003. 65.
  49. Хейфец В. Х., Забежинский М. А., Хролович А. Б., Хавинсон В. Х. Экспериментальные модели хронического простатита. Урология 1999; 5: 48-52.
  50. Feeney D. A., Johnston G. R., Osborne C. A., Tomlinson M. J. Maximum-distention retrograde urethrocystography in healthy male dogs: occurrence and radiographic appearance of urethroprostatic reflux. Am. J. Vet. Res. 1984; 45 (5): 948-952.
  51. Rameriz C. T., Ruiz J. A., Gomez A. Z. et al. A crystallographic study of prostatic calculi. J. Urol. (Baltimore) 1980; 124: 840.
  52. Аляев Ю. Г., Винаров А. З., Синицын В. Е. и др. Микционная спиральная томография уретры в диагностике интрапростатического рефлюкса. Андрол. и генит. хир. 2004; 4: 50-51.
  53. Прокоп М., Галански М. Спиральная и многослойная компьютерная томография. М.: МЕДпресс-информ; 2009; т. 2.
  54. Miller L. J., Fischer K. A., Goralnick S. J. et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59 (4): 603-608.
  55. Мазин П. В., Тарасов Н. И. Методологические инновации дигитального скрининга предстательной железы. Урал. мед. журн. 2008; 2 (42): 85-90.
  56. Rahman N. U., Phonsombat S., Bochinski D. et al. An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. Br. J. Urol. Int. 2007; 100 (3): 658-663.
  57. Мазин П. В. Системно-сравнительный метод оценки влияния социальных, климатических и профессиональных факторов на эректильную функцию и состояние предстательной железы у мужчин Кировской области. В кн.: Материалы Межрегиональной науч.-практ. конф. урологов Урала "Актуальные проблемы урологии и андрологии". : Изд. "АБРИС"; 2007. 174-176.
  58. Мазин П. В. Воздействие профессиональных вредностей на эректильную функцию и состояние предстательной железы у мужчин Кировской области. В кн.: Материалы Межрегиональной науч.-практ. конф. урологов Урала "Актуальные проблемы урологии и андрологии". : Изд. "АБРИС"; 2007. 169-171.
  59. Pang S., Levine L., Chow D et al. Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J. Clin. Endocrinol. 1979; 48: 821-826.
  60. Forest M. G. Plasma androgens (testosterone and 4-androstenedione) and 17-hydroxyprogesterone in the prenatal, prepubertal and peripubertal periods in the human and the rat: Differences between species. J. Steroid. Biochem. 1979; 11: 543-548.
  61. Bronson F. H., Whisett M. J., Hamilton T. H. Responsiveness of accessory glands of adult mice to testosterone: priming with neonatal injections. Endocrinology 1972; 90: 10-16.
  62. Chung L. W. K., McFadden D. K. Sex steroid imprinting and prostatic growth. Insvest. Urol. 1980; 17: 337-342.
  63. Naslund M. J., Coffey D. S. The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J. Urol. (Baltimore) 1986; 136 (5): 1136-1140.
  64. Prins G. S., Birch L. The developmental pattern of androgen receptor regulation in the rat prostate lobes is altered following neonatal exposure to estrogen. Endocrinology 1995; 136: 1303-1314.
  65. Денисов А. Б., Пушкарь Д. Ю., Денисов С. А. Использование кристаллогенных свойств слюны для ранней диагностики рака предстательной железы. Бюл. экспер. биол. 2006; 141 (S): 37-40.
  66. Zhang L., Xiao H., Wong D. J. Salivary biomarkers for clinical applications. Mol. Diagn. Ther. 2009; 13 (4): 245-259.
  67. Kerman B. E., Cheshire A. M., Andrew D. J. From fate to function: the Drosophila trachea and salivary gland as models for tubulogenesis. Differentiation 2006; 74 (7): 326-348.
  68. Liao Q., Kleeff J., Xiao Y. et al. Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis. Histol. Histopatol. 2003; 18 (2): 425-433.
  69. Денисов А. Б. Микрокристаллизация слюны: новые методические подходы. Стоматология 2007; 60 (5): 20-23.
  70. Foresto P., Bioindi C, Racca L. et al. Abnormal glycosylation of soluble ABH antigens in tumors of the urinary tract. Arch. Esp. Urol. 2000; 53 (3): 196-199.
  71. Mita K., Matsubara A., Usui T. Measurement of salivary testosterone by a simple enzyme immunoassay procedure. Nippon Hinyokika Gakkai Zasshi 2005; 96 (6): 610-616.
  72. Ayatollani H., Darabi Mahboub M. R., Mohammadian N. et al. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men. Urol. J. 2007; 4 (4): 238-241.
  73. Udby L., Calafat J., Sorensen O. E. et al. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J. Leukoc. Biol. 2002; 72 (3): 462-469.
  74. Nishimori I., Kohsaki T., Onishi S. et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern. Med 2007; 46 (24): 1983-1989.
  75. Sänchez-Castanón M., de Las Heras-Castano G., López-Hoyos M. Autoimmune pancreatitis: An underdiagnosed autoimmune disease with clinical, imaging and serological features. Autoimmun. Rev. 2010; 9 (4): 237-240.
  76. Uehara T., Hamano H., Kawakami M. et al. Autoimmune pancreatitis-associated prostatitis: Distinct clinicopathological entity. Pathol. Int. 2008; 58 (2): 118-125.
  77. Frank S. A. Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc. Natl. Acad. Sci. USA 2010; 107 (Suppl. 1): 1725-1730.
  78. Parsons C. L., Albo M. Intravesical potassium sensitivity in patients with prostatitis. J. Urol. (Baltimore) 2002; 168 (3): 1054-1057.
  79. Liang C. Z., Guo Q. K., Hao Z. Y. et al. K-channel expression in prostate epithelium and its implications in men with chronic prostatitis. Br. J. Urol. Int. 2006; 97 (1): 190-192.
  80. Vera P. L., Meyer-Siegler K. L. Inflammation of the rat prostate evokes release of macrophage migration inhibitory factor in the bladder: evidence for a viscerovisceral reflex. J. Urol. (Baltimore) 2004; 172 (6): 2440-2445.
  81. Wang W., Bergh A., Damber J. E. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation. Acta Pathol. Microbiol. Immunol. Scand. 2009; 117 (3): 185-195.
  82. Wang W., Bergh A., Damber J. E. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. Prostate 2007; 67 (11): 1238-1246.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies